Health4 years ago
Early results suggest that Alzheimer’s drugs may delay cognitive decline in patients
The study included 257 patients with early-stage symptomatological Alzheimer’s disease. 131 received donanemab and 126 received placebo. Researchers found that donanemab delayed cognitive and routine functioning...
Recent Comments